The Korea Times close
National
  • Politics
  • Diplomacy
  • Defense
  • Labor & Environment
  • Law & Crime
  • Health & Welfare
  • Embassy
  • Seoul & Provinces
  • Education
  • Foreign Communities
  • Obituaries
  • Multicultural Youth Award
Biz & Tech
  • Auto
  • IT
  • Game
  • Manufacturing
  • Retail & Food
  • Energy
  • Construction
  • Airlines
Finance
  • Policies
  • Economy
  • Markets
  • Banks
  • Non-banks
  • Economic Essay Contest
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to the Editor
Lifestyle
  • Arts
  • Books
  • Travel & Cuisine
  • Trend
  • Fashion
  • Around Town
  • Fortune Telling
Entertainment
  • K-pop
  • K-dramas & Shows
  • Movies
  • Music
  • Performances
  • Asia Model Festival
Sports
  • Football
  • Golf
  • Baseball
  • Other Sports
World
  • Asia Pacific
  • Americas
  • Europe & Africa
  • SCMP
Video
  • On the Spot
  • Feature
  • News
Photos
  • Photo News
  • Darkroom
Community
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
National
  • Politics
  • Diplomacy
  • Defense
  • Labor & Environment
  • Law & Crime
  • Health & Welfare
  • Embassy
  • Seoul & Provinces
  • Education
  • Foreign Communities
  • Obituaries
  • Multicultural Youth Award
Sat, January 23, 2021 | 20:30
Bird Flu Medicine Toxic for Teens
Posted : 2008-05-13 17:40
Updated : 2008-05-13 17:40
Mail
Print Preview
Font Size Up
Font Size Down

Students are startled as pigeons flap their wings to fly upward at a park in eastern Seoul, Tuesday. / Yonhap

By Bae Ji-sook
Staff Reporter

Concerns are rising over side effect of bird flu drug Tamiflu on teenagers.

Tamiflu is Swiss-based Hoffman-La Roche's antiviral for general influenza A and B but is also used to combat bird flu. However, worries have surfaced about the possibility of the medicine causing mental disorders among teenagers.

With fear of the H5N1 virus sweeping the nation, the government has doubled the quantity of the drug in storage, as it is the most effective treatment against avian influenza.

Whether to prescribe the pills with risks of side-effects such delusions or other disorders is being widely discussed among medical experts.

Although the drug has been the only medicine accredited to be effective against the H5N1 virus strain by the World Health Organization (WHO), the Japanese and Korean governments restricted its being prescribed to teenagers last year.

The Korea Food and Drug Administration announced that the drug should not be prescribed to those between 10 to 19 years old except for emergencies.

According to Roche, there has not been a reported case of side effects here, but the Seoul Shinmun, a local daily, reported that a woman in her 30s said she had nightmares after taking the drug in 2005.

The government's decision came after Japanese health authorities banned its prescription for teenagers in March 2007.

Japan has imported the drug since 2001, long before its effect on bird flu was acknowledged.

However, since then, there have been 1,268 cases of extraordinary behavior reported, of which 85 percent were from teenagers. They reportedly committed suicide by jumping out of buildings or into cars.

Health experts admit to the dilemma and said when necessary, it should be prescribed with extra prudence.

``We will have no option but to give out the pill once someone contracts the disease. But for teenagers we need to be extra careful and make sure it is prescribed at the most appropriate time,'' Korean Pharmacists for a Democratic Society spokesman Shin Hyeong-geun said. ``Let's hope we will never have to worry about that.''

bjs@koreatimes.co.kr









 
WooriBank
 
  • [INTERVIEW] Ex-US envoy calls China 'malign influence,' urges Seoul to join new alliance
  • World Trade Organization rules in favor of South Korea in lawsuit against US
  • Samsung Electronic seeks Intel chip outsourcing deal
  • Woman gets suspended jail term for assaulting mother-in-law
  • Korea gears up to start COVID-19 vaccinations next month
  • [INTERVIEW] Climate change revolutionaries: Why students in Korea hit the streets
  • Growing number of Koreans refuse life-sustaining treatment
  • Biden orders masks, travel clampdown in new war on COVID-19
  • [INTERVIEW] Korea urged to brace for side effects of 'Bidenomics'
  • Cannonball Joe
  • Seolhyun's first social media posts since AOA bullying scandal get mixed reactions Seolhyun's first social media posts since AOA bullying scandal get mixed reactions
  • Why have K-pop dance practice videos become so popular? Why have K-pop dance practice videos become so popular?
  • [K-POP INTERVIEW] What are MOMOLAND's comfort foods? [VIDEO] [K-POP INTERVIEW] What are MOMOLAND's comfort foods? [VIDEO]
  • Korean National Ballet, KBS criticized for dangerous filming location Korean National Ballet, KBS criticized for dangerous filming location
  • [INTERVIEW] Model-turned-actress Jang Yoon-ju talks about becoming fearless on screen [INTERVIEW] Model-turned-actress Jang Yoon-ju talks about becoming fearless on screen
DARKROOM
  • Biden takes office as 46th president

    Biden takes office as 46th president

  • Biden-Harris inauguration is taking shape

    Biden-Harris inauguration is taking shape

  • Second Trump impeachment

    Second Trump impeachment

  • Pro-Trump rioters breach the US Capitol

    Pro-Trump rioters breach the US Capitol

  • Our children deserve better (Part 2)

    Our children deserve better (Part 2)

WooriBank
  • About Korea Times
  • CEO Message
  • Times History
  • Content Sales
  • Media Kit
  • Contact Us
  • Location
  • Privacy Statement
  • Terms of Service
  • Mobile Service
  • RSS Service
  • Ombudsman
  • hankookilbo
  • Dongwha Group
  • Code of Ethics
Copyright